AKI Arthro Kinetics

RNS Number:2927Y
Arthro Kinetics plc
13 June 2007

                                      


Press Release


                 Arthro Kinetics plc - granted European patent


WEDNESDAY, 13th June 2007 - Arthro Kinetics plc (AIM: AKI) ("Arthro Kinetics"),
the orthopedics company dedicated to regenerating joint mobility and spinal disc
function, announces that its wholly owned subsidiary Arthro Kinetics AG has been
granted a European patent (EP 1 289 574) for "Cartilage Replacement and Methods
for the Production Thereof".

Jason Loveridge, CEO of Arthro Kinetics commented:

"This is excellent news for Arthro Kinetics and validation of the novelty of our
R&D and product portfolio for cartilage regeneration. This patent extends
coverage for our core proprietary technology - from which our first product
CaReS(R) emerged onto the market in 2003 - to an additional 19 European
countries beyond Germany, where the original application was filed in May 2001.
We are continuing to pursue protection across all key commercial markets and, in
this respect, the European patent represents an important piece of intellectual
property protecting our core technology and portfolio of products for cartilage
regeneration".

END


Contact

Jason Loveridge                        Tel: +49 (0)711 305 110 70
Chief Executive, Arthro Kinetics plc






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCILFVVRAIVLID

Arthro Kinetics (LSE:AKI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Arthro Kinetics (LSE:AKI)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024